The Problem With Lilly Is the Problem With Pharma

Eli Lilly’s Alzheimer’s drug trial failure spotlights the industry’s main problem.

from WSJ.com: Markets http://ift.tt/2grEyBO
via https://ifttt.com/ IFTTT